Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$2.23−0.04 (-1.76%)

Close on Nov 13, 2026Market cap $3.37MP/E –Yield –

Apimeds Pharmaceuticals US gross margin

Gross margin is gross profit as a percentage of revenue.

Apimeds Pharmaceuticals US has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?